LBT Innovations (ASX:LBT) Momentum Rank : 0 (As of Jun. 08, 2024)

View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Momentum Rank?

LBT Innovations has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

LBT Innovations Momentum Rank Related Terms

Thank you for viewing the detailed overview of LBT Innovations's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

LBT Innovations (ASX:LBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Anster Street, Adelaide, SA, AUS, 5000

Website

https://www.lbtinnovations.com

LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines